Johnson & Johnson posted a 6.5% increase in third quarter sales of $17.1 billion. Operational results increased 10.8% and the negative impact of currency was 4.3%. Domestic sales increased 13.4%, while international sales increased 1.4%. Positive contributors to operational results were international sales of Listerine oral care products and Neutrogena skin care products, said the company. “Our third-quarter results reflected continued sales momentum driven by strong...